AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 728318 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined preparation of (+)-norpseudoephedrine and senna
Number of subjects: 10
Study 728318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30234848 — intervention group
Group type: EXPERIMENTAL
Intervention: OVRT test battery including metrics of saccades, smooth pursuit tracking, nystagmoid movements, vestibular function, and reaction time latencies.
Number of subjects: 50
Study 30234848 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (n = 170)
Number of subjects: 50
Study 28225674 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanadelumab 300 mg
Number of subjects: 37
Study 28225674 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanadelumab 400 mg
Number of subjects: 37
Study 28225674 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 24610803 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal exposure measurements using a magnetic field dosimeter
Number of subjects: 0
Study 24610803 — intervention group
Group type: COMPARATOR
Intervention: Distance to the bore of the MRI scanner
Number of subjects: 0
Study 22534471 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse follow-up dietary intervention (NFDI) including a structured 8-week program with face-to-face consultation and fortnightly telephone follow-ups
Number of subjects: 82
Study 22534471 — intervention group
Group type: COMPARATOR
Intervention: Conventional care and attendance at a heart health dietary class
Number of subjects: 82
Study 21898496 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib 800 mg/day
Number of subjects: 296
Study 21898496 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib half dose
Number of subjects: 296
Study 21898496 — intervention group
Group type: EXPERIMENTAL
Intervention: sorafenib therapy
Number of subjects: 296
Study 20015433 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese herbal medicine plus conventional treatment
Number of subjects: 28
Study 20015433 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus conventional treatment
Number of subjects: 28
Study 16467013 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician characteristics (e.g., professional orientation, location, and experience)
Number of subjects: 296
Study 16467013 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient factors (e.g., contact with drug subculture, appearance, employment status, social support, having children)
Number of subjects: 296
Study 15583373 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking during pregnancy
Number of subjects: 3774
Study 15583373 — intervention group
Group type: COMPARATOR
Intervention: Never smoked
Number of subjects: 3774
Study 11058618 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium levels (highest quartile)
Number of subjects: 2071
Study 11058618 — intervention group
Group type: COMPARATOR
Intervention: Low selenium levels
Number of subjects: 2071
Study 9353692 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxacurium administered by bolus injection
Number of subjects: 15
Study 9353692 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxacurium administered by 10-min infusion
Number of subjects: 15
Study 9353692 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxacurium with Rtot model (bolus)
Number of subjects: 15
Study 9353692 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxacurium with Rtot model (infusion)
Number of subjects: 15
Study 8385179 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic drink
Number of subjects: 21
Study 8385179 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric control drink
Number of subjects: 21
Study 2868039 — intervention group
Group type: EXPERIMENTAL
Intervention: Peri-incisional mezlocillin
Number of subjects: 140
Study 2868039 — intervention group
Group type: COMPARATOR
Intervention: Rectal metronidazole
Number of subjects: 140
Study 29342506 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH-Plus diet (coach-directed dietary advice, assistance with purchasing DASH-related foods $30/week, home delivery of food)
Number of subjects: 117
Study 29342506 — intervention group
Group type: COMPARATOR
Intervention: Control diet (DASH diet brochure and debit card account $30/week to purchase foods)
Number of subjects: 117
Study 29342506 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline serum UA levels
Number of subjects: 117
Study 28554530 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical Muscle Stimulation (EMS) treatment, 3 times over a period of 1 week, 1-hour sessions each.
Number of subjects: 24
Study 28554530 — intervention group
Group type: COMPARATOR
Intervention: Electrical Muscle Stimulation (EMS) treatment
Number of subjects: 24
Study 26424212 — intervention group
Group type: EXPERIMENTAL
Intervention: SUA quartile III (281-420 mmol/L)
Number of subjects: 12677
Study 26424212 — intervention group
Group type: EXPERIMENTAL
Intervention: SUA quartile IV (420-1640 mmol/L)
Number of subjects: 12677
Study 26424212 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition of SUA as a biomarker
Number of subjects: 12677
Study 23865335 — intervention group
Group type: EXPERIMENTAL
Intervention: Reference preparation of oxaprozin enteric coated tablets (0.4 g)
Number of subjects: 20
Study 23865335 — intervention group
Group type: COMPARATOR
Intervention: Test preparation of oxaprozin enteric coated tablets (0.4 g)
Number of subjects: 20
Study 21547496 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg (n=26)
Number of subjects: 59
Study 21547496 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=25)
Number of subjects: 59
Study 21547496 — intervention group
Group type: EXPERIMENTAL
Intervention: Vildagliptin 100 mg
Number of subjects: 59
Study 21547496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 19002650 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline usual formulation
Number of subjects: 54
Study 19002650 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline liquid oral concentrate (LOC) formulation
Number of subjects: 54
Study 15964100 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal insulin (20 or 40 IU)
Number of subjects: 61
Study 15964100 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 61
Study 12877701 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual coil defibrillation lead system (group 1, n = 38)
Number of subjects: 76
Study 12877701 — intervention group
Group type: COMPARATOR
Intervention: Single coil defibrillation lead system (group 2, n = 38)
Number of subjects: 76
Study 12877701 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (dual and single coil)
Number of subjects: 76
Study 11461738 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (1.6 mg/kg/day)
Number of subjects: 20
Study 11461738 — intervention group
Group type: COMPARATOR
Intervention: Digoxin and diuretics
Number of subjects: 20
Study 9923363 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementing formative assessment and learning contracts
Number of subjects: 0
Study 8091754 — intervention group
Group type: EXPERIMENTAL
Intervention: Live cold-adapted attenuated vaccine
Number of subjects: 0
Study 8091754 — intervention group
Group type: COMPARATOR
Intervention: Whole-virus inactivated trivalent vaccine
Number of subjects: 0
Study 8091754 — intervention group
Group type: EXPERIMENTAL
Intervention: All vaccines (including live and inactivated)
Number of subjects: 0
Study 8091754 — intervention group
Group type: EXPERIMENTAL
Intervention: Revaccinated children with preexisting antibody
Number of subjects: 0
Study 8091754 — intervention group
Group type: EXPERIMENTAL
Intervention: Annual influenza revaccination
Number of subjects: 0
Study 8091754 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine strains
Number of subjects: 0
Study 3413454 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 30
Study 3413454 — intervention group
Group type: COMPARATOR
Intervention: No physiotherapy (Control)
Number of subjects: 30
Study 31313331 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity drinking (2+ times binge level)
Number of subjects: 2442
Study 31313331 — intervention group
Group type: COMPARATOR
Intervention: Standard binge drinking (1 to 2 times binge level)
Number of subjects: 2442
Study 29231342 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm needling pretreatment (once a day) at specific acupuncture points for three months before embryo transfer, along with antibiotics and oral progesterone after ovulation.
Number of subjects: 56
Study 29231342 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with antibiotics in the menstrual period and oral progesterone after ovulation.
Number of subjects: 56
Study 25925226 — intervention group
Group type: EXPERIMENTAL
Intervention: HOME Plus intervention (community-based program with ten monthly sessions and five motivational calls)
Number of subjects: 81
Study 25925226 — intervention group
Group type: EXPERIMENTAL
Intervention: HOME Plus intervention (cooking with families, learning to eat healthfully, trying new recipes)
Number of subjects: 81
Study 25925226 — intervention group
Group type: COMPARATOR
Intervention: Attention-only control group (not explicitly detailed in the abstract)
Number of subjects: 81
Study 23938154 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured health promotion programme (physical activity and education programme) executed in five day-activity centres for eight months.
Number of subjects: 0
Study 23938154 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (control group) in five other centres.
Number of subjects: 0
Study 23938154 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured health promotion programme (physical activity and education programme).
Number of subjects: 0
Study 21766223 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror visual feedback from the less-impaired arm
Number of subjects: 0
Study 21766223 — intervention group
Group type: COMPARATOR
Intervention: Actual visual feedback from the two arms
Number of subjects: 0
Study 21766223 — intervention group
Group type: COMPARATOR
Intervention: Mirror visual feedback from the impaired arm
Number of subjects: 0
Study 21766223 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror visual feedback (general)
Number of subjects: 0
Study 18551819 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% levobupivacaine (Levobupivacaine group, n = 96)
Number of subjects: 186
Study 18551819 — intervention group
Group type: COMPARATOR
Intervention: IV PCA morphine only (Morphine PCA group, n = 90)
Number of subjects: 186
Study 18551819 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.125% levobupivacaine (Levobupivacaine group)
Number of subjects: 186
Study 18551819 — intervention group
Group type: COMPARATOR
Intervention: IV PCA morphine only (Morphine PCA group)
Number of subjects: 186
Study 16520410 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g/day of ginseng for 12 weeks
Number of subjects: 52
Study 16520410 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 52
Study 12775894 — intervention group
Group type: EXPERIMENTAL
Intervention: Emla cream
Number of subjects: 12
Study 12775894 — intervention group
Group type: COMPARATOR
Intervention: Placebo occlusive dressing
Number of subjects: 12
Study 10551577 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine (0.25%, 1 ml/kg)
Number of subjects: 81
Study 10551577 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (0.25%, 1 ml/kg)
Number of subjects: 81
Study 8531998 — intervention group
Group type: COMPARATOR
Intervention: Carbimazole alone for 17 months
Number of subjects: 111
Study 8531998 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbimazole plus T4 for 17 months and T4 alone for 18 months
Number of subjects: 111
Study 1860289 — intervention group
Group type: EXPERIMENTAL
Intervention: Malarial chemoprophylaxis (300 mg chloroquine weekly for at least one year)
Number of subjects: 92
Study 1860289 — intervention group
Group type: COMPARATOR
Intervention: Non-chemoprophylaxis (not on regimen for at least one year)
Number of subjects: 92
Study 6631350 — intervention group
Group type: EXPERIMENTAL
Intervention: Free visit with new physician
Number of subjects: 0
Study 6631350 — intervention group
Group type: EXPERIMENTAL
Intervention: Reassignment to new physician providers
Number of subjects: 0
Study 31123090 — intervention group
Group type: COMPARATOR
Intervention: Bedsheet only
Number of subjects: 28
Study 31123090 — intervention group
Group type: EXPERIMENTAL
Intervention: Bedsheet and intravenous pole
Number of subjects: 28
Study 31524681 — intervention group
Group type: EXPERIMENTAL
Intervention: High-grade gliomas with low FDG uptake
Number of subjects: 12
Study 31524681 — intervention group
Group type: COMPARATOR
Intervention: High-grade gliomas with high FDG uptake
Number of subjects: 12
Study 29197371 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-focused intervention to improve communication and decision-making regarding clinical trial participation.
Number of subjects: 0
Study 29197371 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician-focused intervention to improve communication and trial offers.
Number of subjects: 0
Study 29197371 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-focused intervention to improve communication quality during clinical interactions.
Number of subjects: 0
Study 29197371 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-focused intervention to enhance understanding of trials offered.
Number of subjects: 0
Study 29197371 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-focused intervention to increase actual enrollment in trials.
Number of subjects: 0
Study 25839390 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative Muscular Movement Technique (IMMT)
Number of subjects: 38
Study 25839390 — intervention group
Group type: COMPARATOR
Intervention: Swedish massage
Number of subjects: 38
Study 23306815 — intervention group
Group type: EXPERIMENTAL
Intervention: Flowchart
Number of subjects: 83
Study 23306815 — intervention group
Group type: COMPARATOR
Intervention: Non-flowchart
Number of subjects: 83
Study 21664280 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial stress task (n=18)
Number of subjects: 38
Study 21664280 — intervention group
Group type: COMPARATOR
Intervention: Non‐stressful control procedure (n=20)
Number of subjects: 38
Study 18715524 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 30 mg
Number of subjects: 48
Study 18715524 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 40 mg
Number of subjects: 48
Study 18715524 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 50 mg
Number of subjects: 48
Study 18715524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 16423208 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous cisplatin therapy
Number of subjects: 49
Study 16423208 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous OK432 therapy
Number of subjects: 49
Study 16423208 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy with cisplatin and OK432
Number of subjects: 49
Study 15052382 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone (1000 mg i.v.)
Number of subjects: 872
Study 15052382 — intervention group
Group type: EXPERIMENTAL
Intervention: Sivelestat (0.20 mg/kg per h)
Number of subjects: 872
Study 15052382 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunoglobulin (5 g for 3 days)
Number of subjects: 872
Study 15052382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 872
Study 15052382 — intervention group
Group type: COMPARATOR
Intervention: Sivelestat (0.004 mg/kg per h)
Number of subjects: 872
Study 15052382 — intervention group
Group type: COMPARATOR
Intervention: Control group for immunoglobulin
Number of subjects: 872
Study 10902749 — intervention group
Group type: EXPERIMENTAL
Intervention: Short Form 36 (SF-36) modified health survey
Number of subjects: 693
Study 10902749 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Assessment Questionnaire (HAQ) disability index
Number of subjects: 693
Study 10902749 — intervention group
Group type: COMPARATOR
Intervention: RA severity measures (patient and physician global assessments, joint swelling and tenderness counts, global pain assessment)
Number of subjects: 693
Study 8823657 — intervention group
Group type: EXPERIMENTAL
Intervention: FEV1 residual less than -1.2 L (optimal cut-off)
Number of subjects: 0
Study 8823657 — intervention group
Group type: EXPERIMENTAL
Intervention: FEV1 and FEV1/FVC parameters
Number of subjects: 0
Study 8823657 — intervention group
Group type: EXPERIMENTAL
Intervention: False-positive and false-negative decisions
Number of subjects: 0
Study 1531318 — intervention group
Group type: EXPERIMENTAL
Intervention: Packing of the presacral space after suture of the pelvic peritoneum
Number of subjects: 102
Study 1531318 — intervention group
Group type: EXPERIMENTAL
Intervention: Suture of the pelvic peritoneum and perineal wound, leaving two drains through the perineum
Number of subjects: 102
Study 1531318 — intervention group
Group type: EXPERIMENTAL
Intervention: No suture of the pelvic peritoneum, and primary closure of the perineal wound, leaving drains through the abdomen for physiological saline irrigation
Number of subjects: 102
Study 6380858 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily metoprolol (Betaloc tablets)
Number of subjects: 389
Study 6380858 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily metoprolol (Betaloc Durules)
Number of subjects: 389
Study 3524185 — intervention group
Group type: EXPERIMENTAL
Intervention: Potassium supplementation (60 to 80 mmol/day orally)
Number of subjects: 19
Study 3524185 — intervention group
Group type: COMPARATOR
Intervention: Potassium-sparing diuretic amiloride
Number of subjects: 19
Study 31364415 — intervention group
Group type: EXPERIMENTAL
Intervention: Roc>95 (n=15)
Number of subjects: 45
Study 31364415 — intervention group
Group type: EXPERIMENTAL
Intervention: Roc50 (n=14)
Number of subjects: 45
Study 31364415 — intervention group
Group type: COMPARATOR
Intervention: Control (n=16)
Number of subjects: 45
Study 31364415 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 45
Study 29759656 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency medicine residency training
Number of subjects: 766
Study 29759656 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported health concerns
Number of subjects: 766
Study 29759656 — intervention group
Group type: EXPERIMENTAL
Intervention: Sources of stress
Number of subjects: 766
Study 29759656 — intervention group
Group type: EXPERIMENTAL
Intervention: Career satisfaction
Number of subjects: 766
Study 27929346 — intervention group
Group type: COMPARATOR
Intervention: d-amphetamine 0 mg (placebo)
Number of subjects: 40
Study 27929346 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine 1 mg
Number of subjects: 40
Study 27929346 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine 2 mg
Number of subjects: 40
Study 25045832 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic-enriched foods or dietary supplement containing SYNBIO®
Number of subjects: 200
Study 25045832 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 200
Study 22512861 — intervention group
Group type: EXPERIMENTAL
Intervention: HDHK program
Number of subjects: 53
Study 22512861 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 53
Study 20810998 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil (maximum 10 mg per day)
Number of subjects: 23
Study 20810998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 19075497 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid at 1 mg/day
Number of subjects: 202
Study 19075497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study 16162698 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol, 50 microg
Number of subjects: 39
Study 16162698 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol, 12 microg
Number of subjects: 39
Study 12952833 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose paclitaxel (1.28 microg/mm2)
Number of subjects: 39
Study 12952833 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose paclitaxel (3.10 microg/mm2)
Number of subjects: 39
Study 12952833 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive remodeling lesions
Number of subjects: 39
Study 12952833 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate remodeling lesions
Number of subjects: 39
Study 12952833 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative remodeling lesions
Number of subjects: 39
Study 10232867 — intervention group
Group type: EXPERIMENTAL
Intervention: Diary cards used alone
Number of subjects: 67
Study 10232867 — intervention group
Group type: EXPERIMENTAL
Intervention: Diary cards with physician assessment
Number of subjects: 67
Study 10232867 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual analogue scale
Number of subjects: 67
Study 10232867 — intervention group
Group type: EXPERIMENTAL
Intervention: Likert scales
Number of subjects: 67
Study 10232867 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily averages of symptoms
Number of subjects: 67
Study 10232867 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly averages of symptoms
Number of subjects: 67
Study 10232867 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-week intervals during treatment
Number of subjects: 67
Study 10232867 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of life questionnaires
Number of subjects: 67
Study 10232867 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychometric test
Number of subjects: 67
Study 8681000 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Counseling (IPC)
Number of subjects: 76
Study 1925430 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually planned energy-restricted diet of 1000-1500 kcal per day, weekly discussions, and various leaflets on diet modification and increase of physical activity
Number of subjects: 49
Study 1925430 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 49
Study 6660028 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (20 g X 4/day)
Number of subjects: 3
Study 6660028 — intervention group
Group type: EXPERIMENTAL
Intervention: Haemodialysis (3 treatments of 5 hours each)
Number of subjects: 3
Study 6660028 — intervention group
Group type: COMPARATOR
Intervention: Activated charcoal
Number of subjects: 3